Health & Fitness
Health and Fitness
Health and Fitness
Fri, October 21, 2011
Thu, October 20, 2011
Unigene to Present at the 10th Annual BIO Investor Forum on October 25, 2011
BOONTON, N.J.--([ BUSINESS WIRE ])--Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that Ashleigh Palmer, President and Chief Executive Officer will be presenting a corporate overview at the 10th Annual BIO Investor Forum being held in San Francisco, CA. Mr. Palmera™s live presentation is scheduled to begin at 10:00 a.m. Pacific Time on Tuesday, October 25, 2011.
Individuals can listen to a live webcast of the presentation by logging on to the Investors and Media section under the Events tab of the Unigene web site, [ http://www.unigene.com ]. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.
About Unigene Laboratories, Inc.
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligencea" platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.
